Search filters

List of works by Orhan Sencan

Bevacizumab + capecitabine as maintenance therapy after initial bevacizumab + XELOX treatment in previously untreated patients with metastatic colorectal cancer: phase III 'Stop and Go' study results--a Turkish Oncology Group Trial.

scientific article published on 12 November 2013

Glutathione peroxidase activity in serum during acute myocardial infarction and unstable angina pectoris

scientific article published on 01 September 1993

Hemodynamic changes in the early phase of artificially created arteriovenous fistula: color Doppler ultrasonographic findings

scientific article published on 01 December 1997

Ileus secondary to pancreatic pseudocyst

scientific article published on 01 January 1998

Inhibitory effect of 5-fluorouracil on cytochrome P450 2C9 activity in cancer patients

scientific article published in February 2006

Metastatic gastrointestinal stromal tumor with long-term response after treatment with concomitant radiotherapy and imatinib mesylate.

scientific article published in September 2007

Mn- and Cu,Zn-superoxide dismutase activities during acute myocardial infarction

scientific article published on 01 May 1993

Prostatic acid phosphatase and prostate specific antigen in liver disease

scientific article published on 01 January 1996

Serum immunoglobulin E (Ig E) levels after myocardial infarction

scientific article published on 01 January 1997

Synchronous presentation of nasopharyngeal and renal cell carcinomas.

scientific article published in May 2006

Tamoxifen inhibits cytochrome P450 2C9 activity in breast cancer patients

scientific article published on 01 August 2006

The effect of two different doses of oral clodronate on pain in patients with bone metastases

scientific article published on 01 September 1999

The effect of venous thromboembolism on survival of cancer patients and its relationship with serum levels of factor VIII and vascular endothelial growth factor: a prospective matched-paired study

scientific article published on 01 October 2006

The symptomatic benefit (the clinical benefit response) from the second-line chemotherapy in patients with advanced gastric adenocarcinoma.

scientific article published in January 2008